{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates LRRK2 mutations in Parkinson's disease, focusing on their interaction with 14-3-3 proteins and kinase activity.",
          "judgment": "Yes",
          "reasoning": "Parkinson's disease is linked to LRRK2 mutations affecting protein interactions and kinase function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein interaction assays and kinase activity measurements were used, which are relevant to disease mechanisms.",
          "judgment": "Yes",
          "reasoning": "Assays model the molecular basis of Parkinson's via LRRK2 function."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were not explicitly mentioned.",
          "judgment": "No",
          "reasoning": "Lack of explicit controls, but techniques are standard."
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Assays are standard techniques in the field.",
          "judgment": "Yes",
          "reasoning": "Techniques like kinase assays and protein interaction studies are validated."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses provided.",
          "judgment": "No",
          "reasoning": "Functional impact is noted without OddsPath calculation."
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "G",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates LRRK2 mutations in Parkinson's disease, focusing on their interaction with 14-3-3 proteins and kinase activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein interaction assays and kinase activity measurements were used, which are relevant to disease mechanisms.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were not explicitly mentioned.",
          "judgment": "No"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Assays are standard techniques in the field.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses provided.",
          "judgment": "No"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "H",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441H"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates LRRK2 mutations in Parkinson's disease, focusing on their interaction with 14-3-3 proteins and kinase activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein interaction assays and kinase activity measurements were used, which are relevant to disease mechanisms.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were not explicitly mentioned.",
          "judgment": "No"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Assays are standard techniques in the field.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses provided.",
          "judgment": "No"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates LRRK2 mutations in Parkinson's disease, focusing on their interaction with 14-3-3 proteins and kinase activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein interaction assays and kinase activity measurements were used, which are relevant to disease mechanisms.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were not explicitly mentioned.",
          "judgment": "No"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Assays are standard techniques in the field.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses provided.",
          "judgment": "No"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates LRRK2 mutations in Parkinson's disease, focusing on their interaction with 14-3-3 proteins and kinase activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein interaction assays and kinase activity measurements were used, which are relevant to disease mechanisms.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were not explicitly mentioned.",
          "judgment": "No"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Assays are standard techniques in the field.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses provided.",
          "judgment": "No"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "H",
          "position": "1728"
        },
        "variant_string_id": "LRRK2 R1728H"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates LRRK2 mutations in Parkinson's disease, focusing on their interaction with 14-3-3 proteins and kinase activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein interaction assays and kinase activity measurements were used, which are relevant to disease mechanisms.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were not explicitly mentioned.",
          "judgment": "No"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Assays are standard techniques in the field.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses provided.",
          "judgment": "No"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "T",
          "position": "TBD"
        },
        "variant_string_id": "LRRK2 TBDT"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates LRRK2 mutations in Parkinson's disease, focusing on their interaction with 14-3-3 proteins and kinase activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein interaction assays and kinase activity measurements were used, which are relevant to disease mechanisms.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were not explicitly mentioned.",
          "judgment": "No"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Assays are standard techniques in the field.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses provided.",
          "judgment": "No"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    }
  ]
}